Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
12.15
+0.33 (2.79%)
At close: Mar 13, 2026, 4:00 PM EDT
12.14
-0.01 (-0.08%)
After-hours: Mar 13, 2026, 6:51 PM EDT

LENZ Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
17.5-----
Gross Profit
17.5-----
Selling, General & Admin
60.8628.8112.9332.8522.514.38
Research & Development
24.5429.859.572.7937.939.12
Total Operating Expenses
85.458.6172.43105.6460.4413.5
Operating Income
-67.9-58.61-72.43-105.64-60.44-13.5
Interest Income
9.348.552.194.590.02-0.04
Other Non-Operating Income (Expense)
0.180.290.09--10.34-54.83
Total Non-Operating Income (Expense)
9.528.842.284.59-10.32-54.87
Pretax Income
-58.38-49.77-70.15-101.05-70.76-68.37
Provision for Income Taxes
0.50-0.18---
Net Income
-58.88-49.77-69.97-101.05-70.76-68.37
Net Income to Common
-58.88-49.77-69.97-101.05-70.76-68.37
Shares Outstanding (Basic)
282121840
Shares Outstanding (Diluted)
282121840
Shares Change (YoY)
87.73%986.27%-89.05%332.92%1166.12%555489859.11%
EPS (Basic)
-2.11-2.34-35.71-5.65-17.15-209.51
EPS (Diluted)
-2.11-2.34-35.71-5.65-17.15-209.51
Free Cash Flow
-46.16-59.86-60.41-94.57-58.59-10.27
Free Cash Flow Per Share
-1.65-2.81-30.84-11.39-14.18-31.46
Gross Margin
100.00%-----
Operating Margin
-388.00%-----
Profit Margin
-336.47%-----
FCF Margin
-263.78%-----
EBITDA
-67.7-58.55-72.41-103.29-59.71-13.38
EBITDA Margin
-386.83%-----
EBIT
-67.9-58.61-72.43-105.64-60.44-13.5
EBIT Margin
-388.00%-----
Effective Tax Rate
-0.86%-0.00%0.26%0.00%0.00%0.00%
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q